Join P95 Julius Clinical at the American Epilepsy Society (AES) Annual Meeting in Denver, CO from December 4-8, 2026.

Stop by booth #3209 to meet our neuroscience experts at the 2026 AES Annual Meeting and discover how P95 Julius Clinical supports high-quality clinical research and real-world evidence generation across complex neurological and psychiatric conditions. We partner with sponsors to navigate the unique challenges of drug development, delivering tailored strategies that accelerate timelines, generate meaningful evidence, and maintain scientific rigor from early-phase studies through post-approval research.

Let’s Meet in Denver!

Connect with our team at the ECNP Congress to discuss how we can support your next neuroscience clinical trial.

Name(Required)

Advancing Neuroscience Clinical Development with Confidence

P95 Julius Clinical offers comprehensive support across all phases of clinical development. With deep expertise in central nervous system diseases, we help bring innovative therapies to patients faster. From protocol development to study execution, we provide a fully integrated approach designed to optimize outcomes at every stage.

Explore our neuroscience expertise.

Why P95 Julius Clinical?

Neuroscience trials present distinct challenges, from complex endpoints to patient variability and recruitment barriers. P95 Julius Clinical combines scientific expertise with operational precision to address these challenges effectively.

With our strong global network and experienced in-house teams, we deliver customized solutions aligned with your development goals, ensuring high-quality data and reliable study execution.